Microsoft and Causaly Integration Accelerates Biopharma R&D Through AI-Driven Scientific Reasoning

Revolutionizing Life Sciences with Integrated AI

The biopharma industry is currently facing a data paradox: while R&D teams are generating massive amounts of computational data, the process of interpreting this information remains a significant bottleneck. At the recent Microsoft Build 2026 event, Causaly and Microsoft announced a strategic partnership aimed at bridging this gap. By combining Microsoft Discovery’s high-performance simulation capabilities with Causaly’s advanced knowledge-graph technology, researchers can now perform complex scientific analysis within a single, unified environment.

Read the full announcement on cadcamcaeworks

‍